Skip to main content

Andreu Vilaseca Jolonch

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Andreu Vilaseca Jolonch

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Complicacions neurològiques associades a cèl·lules CAR-T (CAR-T: Chimeric Antigen Receptor T-cell)

IP: Manuel Comabella Lopez
Collaborators: Andreu Vilaseca Jolonch, Miriam Izquierdo Sans
Funding agency: Fundació Institut de Recerca HUVH
Funding: 35000
Reference: HUVH/BPFSE_CM/2022/VILASECA
Duration: 01/06/2022 - 31/05/2023

Neuroimmunologia clínica

IP: Mar Tintore Subirana
Collaborators: Miriam Izquierdo Sans, Andreu Vilaseca Jolonch
Funding agency: Instituto de Salud Carlos III
Funding: 65000
Reference: CM22/00247
Duration: 01/03/2023 - 28/02/2025

Related news

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Related professionals

García Adán, Bernat

García Adán, Bernat

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Read more
Paula Granado Martinez

Paula Granado Martinez

Postdoctoral researcher
Biomedical Research in Melanoma
Read more
Piazuelo Espinosa, Sergi

Piazuelo Espinosa, Sergi

Shock, Organ Dysfunction and Resuscitation
Read more
Roberto Vélez Villa

Roberto Vélez Villa

Head of group
Musculoskeletal Tissue Engineering
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.